Abstract
The X-ray crystal structure of the complex between the anthracycline idarubicin and d(CGATCG) has been solved by molecular replacement and refined to a resolution of 2.0 A. The final R-factor is 0.19 for 3768 reflections with Fo > or = 2 sigma (Fo). The complex crystallizes in the trigonal space group P31 with unit cell parameters a = b = 52.996(4), c = 33.065(2) A, alpha = beta = 90 degree, gamma = 120 degree. The asymmetric unit consists of two duplexes, each one being complexed with two idarubicin drugs intercalated at the CpG steps, one spermine and 160 water molecules. The molecular packing underlines major groove-major groove interactions between neighbouring helices, and an unusually low value of the occupied fraction of the unit cell due to a large solvent channel of approximately 30 A diameter. This is the first trigonal crystal form of a DNA-anthracycline complex. The structure is compared with the previously reported structure of the same complex crystallizing in a tetragonal form. The geometry of both the double helices and the intercalation site are conserved as are the intramolecular interactions despite the different crystal forms.
Full text
PDF






Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arcamone F., Bernardi L., Giardino P., Patelli B., Marco A., Casazza A. M., Pratesi G., Reggiani P. Synthesis and antitumor activity of 4-demethoxydaunorubicin, 4-demethoxy-7,9-diepidaunorubicin, and their beta anomers. Cancer Treat Rep. 1976 Jul;60(7):829–834. [PubMed] [Google Scholar]
- Berman H. M., Olson W. K., Beveridge D. L., Westbrook J., Gelbin A., Demeny T., Hsieh S. H., Srinivasan A. R., Schneider B. The nucleic acid database. A comprehensive relational database of three-dimensional structures of nucleic acids. Biophys J. 1992 Sep;63(3):751–759. doi: 10.1016/S0006-3495(92)81649-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Daghestani A. N., Arlin Z. A., Leyland-Jones B., Gee T. S., Kempin S. J., Mertelsmann R., Budman D., Schulman P., Baratz R., Williams L. Phase I and II clinical and pharmacological study of 4-demethoxydaunorubicin (idarubicin) in adult patients with acute leukemia. Cancer Res. 1985 Mar;45(3):1408–1412. [PubMed] [Google Scholar]
- Definitions and nomenclature of nucleic acid structure parameters. J Mol Biol. 1989 Feb 20;205(4):787–791. doi: 10.1016/0022-2836(89)90324-0. [DOI] [PubMed] [Google Scholar]
- Drew H. R., Dickerson R. E. Structure of a B-DNA dodecamer. III. Geometry of hydration. J Mol Biol. 1981 Sep 25;151(3):535–556. doi: 10.1016/0022-2836(81)90009-7. [DOI] [PubMed] [Google Scholar]
- Fisher J. F., Aristoff P. A. The chemistry of DNA modification by antitumor antibiotics. Prog Drug Res. 1988;32:411–498. doi: 10.1007/978-3-0348-9154-7_12. [DOI] [PubMed] [Google Scholar]
- Gallois B., d'Estaintot B. L., Brown T., Hunter W. N. The structure of an idarubicin-d(TGATCA) complex at high resolution. Acta Crystallogr D Biol Crystallogr. 1993 May 1;49(Pt 3):311–317. doi: 10.1107/S0907444992009983. [DOI] [PubMed] [Google Scholar]
- Gao Y. G., Wang A. H. Influence of aglycone modifications on the binding of anthracycline drugs to DNA: the molecular structure of idarubicin and 4-O-demethyl-11-deoxydoxorubicin complexed to d(CGATCG). Anticancer Drug Des. 1991 Jul;6(3):137–149. [PubMed] [Google Scholar]
- Langlois d'Estaintot B., Gallois B., Brown T., Hunter W. N. The molecular structure of a 4'-epiadriamycin complex with d(TGATCA) at 1.7A resolution: comparison with the structure of 4'-epiadriamycin d(TGTACA) and d(CGATCG) complexes. Nucleic Acids Res. 1992 Jul 25;20(14):3561–3566. doi: 10.1093/nar/20.14.3561. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Leonard G. A., Brown T., Hunter W. N. Anthracycline binding to DNA. High-resolution structure of d(TGTACA) complexed with 4'-epiadriamycin. Eur J Biochem. 1992 Feb 15;204(1):69–74. doi: 10.1111/j.1432-1033.1992.tb16606.x. [DOI] [PubMed] [Google Scholar]
- Leonard G. A., Hambley T. W., McAuley-Hecht K., Brown T., Hunter W. N. Anthracycline-DNA interactions at unfavourable base-pair triplet-binding sites: structures of d(CGGCCG)/daunomycin and d(TGGCCA)/adriamycin complexes. Acta Crystallogr D Biol Crystallogr. 1993 Sep 1;49(Pt 5):458–467. doi: 10.1107/S090744499300527X. [DOI] [PubMed] [Google Scholar]
- Moore M. H., Hunter W. N., d'Estaintot B. L., Kennard O. DNA-drug interactions. The crystal structure of d(CGATCG) complexed with daunomycin. J Mol Biol. 1989 Apr 20;206(4):693–705. doi: 10.1016/0022-2836(89)90577-9. [DOI] [PubMed] [Google Scholar]
- Quigley G. J., Wang A. H., Ughetto G., van der Marel G., van Boom J. H., Rich A. Molecular structure of an anticancer drug-DNA complex: daunomycin plus d(CpGpTpApCpG). Proc Natl Acad Sci U S A. 1980 Dec;77(12):7204–7208. doi: 10.1073/pnas.77.12.7204. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Westhof E., Dumas P., Moras D. Crystallographic refinement of yeast aspartic acid transfer RNA. J Mol Biol. 1985 Jul 5;184(1):119–145. doi: 10.1016/0022-2836(85)90048-8. [DOI] [PubMed] [Google Scholar]





